Literature DB >> 12791805

Attitudes about prescribing take-home naloxone to injection drug users for the management of heroin overdose: a survey of street-recruited injectors in the San Francisco Bay Area.

Karen H Seal1, Moher Downing, Alex H Kral, Shannon Singleton-Banks, Jon-Paul Hammond, Jennifer Lorvick, Dan Ciccarone, Brian R Edlin.   

Abstract

Naloxone, an injectable opiate antagonist, can immediately reverse an opiate overdose and prevent overdose death. We sought to determine injection drug users' (IDUs) attitudes about being prescribed take-home naloxone. During November 1999 to February 2000, we surveyed 82 street-recruited IDUs from the San Francisco Bay Area of California who had experienced one or more heroin overdose events. We used a questionnaire that included structured and open-ended questions. Most respondents (89%) had witnessed an overdose, and 90% reported initially attempting lay remedies in an effort to help companions survive. Only 51% reported soliciting emergency assistance (calling 911) for the last witnessed overdose, with most hesitating due to fear of police involvement. Of IDUs surveyed, 87% were strongly in favor of participating in an overdose management training program to receive take-home naloxone and training in resuscitation techniques. Nevertheless, respondents expressed a variety of concerning attitudes. If provided naloxone, 35% predicted that they might feel comfortable using greater amounts of heroin, 62% might be less inclined to call 911 for an overdose, 30% might leave an overdose victim after naloxone resuscitation, and 46% might not be able to dissuade the victim from using heroin again to alleviate withdrawal symptoms induced by naloxone. Prescribing take-home naloxone to IDUs with training in its use and in resuscitation techniques may represent a life-saving, peer-based adjunct to accessing emergency services. Nevertheless, strategies for overcoming potential risks associated with the use of take-home naloxone would need to be emphasized in an overdose management training program.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12791805      PMCID: PMC3456285          DOI: 10.1093/jurban/jtg032

Source DB:  PubMed          Journal:  J Urban Health        ISSN: 1099-3460            Impact factor:   3.671


  28 in total

1.  Peer-initiated overdose resuscitation: fellow drug users could be mobilised to implement resuscitation.

Authors: 
Journal:  Int J Drug Policy       Date:  2000-12-01

2.  The self-reporting of cocaine use.

Authors:  J K Watters; R Needle; B S Brown; N Weatherby; R Booth; M Williams
Journal:  JAMA       Date:  1992-11-04       Impact factor: 56.272

3.  Trends in risk behavior and HIV seroprevalence in heterosexual injection drug users in San Francisco, 1986-1992.

Authors:  J K Watters
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1994-12

4.  Are heroin overdose deaths related to patient release after prehospital treatment with naloxone?

Authors:  G M Vilke; J Buchanan; J V Dunford; T C Chan
Journal:  Prehosp Emerg Care       Date:  1999 Jul-Sep       Impact factor: 3.077

5.  Overdose among heroin users in Sydney, Australia: II. responses to overdose.

Authors:  S Darke; J Ross; W Hall
Journal:  Addiction       Date:  1996-03       Impact factor: 6.526

6.  Self-reported overdose among injecting drug users in London: extent and nature of the problem.

Authors:  B Powis; J Strang; P Griffiths; C Taylor; S Williamson; J Fountain; M Gossop
Journal:  Addiction       Date:  1999-04       Impact factor: 6.526

7.  Harnessing peer networks as an instrument for AIDS prevention: results from a peer-driven intervention.

Authors:  R S Broadhead; D D Heckathorn; D L Weakliem; D L Anthony; H Madray; R J Mills; J Hughes
Journal:  Public Health Rep       Date:  1998-06       Impact factor: 2.792

8.  Out-of-hospital treatment of opioid overdoses in an urban setting.

Authors:  K A Sporer; J Firestone; S M Isaacs
Journal:  Acad Emerg Med       Date:  1996-07       Impact factor: 3.451

9.  Heroin-related deaths in New South Wales, 1992: toxicological findings and circumstances.

Authors:  D Zador; S Sunjic; S Darke
Journal:  Med J Aust       Date:  1996-02-19       Impact factor: 7.738

10.  Is admission after intravenous heroin overdose necessary?

Authors:  D A Smith; L Leake; J R Loflin; D M Yealy
Journal:  Ann Emerg Med       Date:  1992-11       Impact factor: 5.721

View more
  38 in total

1.  Prevalence and correlates of opiate overdose among young injection drug users in a large U.S. city.

Authors:  Susan G Sherman; Yingkai Cheng; Alexander H Kral
Journal:  Drug Alcohol Depend       Date:  2006-11-15       Impact factor: 4.492

2.  Psychiatrists as administrators: the perspective of a mental health department psychiatrist.

Authors:  Andrew Kolodny
Journal:  Psychiatr Q       Date:  2007-09

3.  Heroin uncertainties: Exploring users' perceptions of fentanyl-adulterated and -substituted 'heroin'.

Authors:  Daniel Ciccarone; Jeff Ondocsin; Sarah G Mars
Journal:  Int J Drug Policy       Date:  2017-07-18

4.  Intravenous use of illicit buprenorphine/naloxone to reverse an acute heroin overdose.

Authors:  Michael A Yokell; Nickolas D Zaller; Traci C Green; Michelle McKenzie; Josiah D Rich
Journal:  J Opioid Manag       Date:  2012 Jan-Feb

5.  Attitudes Toward Naloxone Prescribing in Clinical Settings: A Qualitative Study of Patients Prescribed High Dose Opioids for Chronic Non-Cancer Pain.

Authors:  Shane R Mueller; Stephen Koester; Jason M Glanz; Edward M Gardner; Ingrid A Binswanger
Journal:  J Gen Intern Med       Date:  2016-10-31       Impact factor: 5.128

6.  Physicians' knowledge of and willingness to prescribe naloxone to reverse accidental opiate overdose: challenges and opportunities.

Authors:  Leo Beletsky; Robin Ruthazer; Grace E Macalino; Josiah D Rich; Litjen Tan; Scott Burris
Journal:  J Urban Health       Date:  2007-01       Impact factor: 3.671

7.  Attitudes of Australian heroin users to peer distribution of naloxone for heroin overdose: perspectives on intranasal administration.

Authors:  Debra Kerr; Paul Dietze; Anne-Maree Kelly; Damien Jolley
Journal:  J Urban Health       Date:  2008-03-18       Impact factor: 3.671

8.  Overdose experiences among injection drug users in Bangkok, Thailand.

Authors:  M-J Milloy; Nadia Fairbairn; Kanna Hayashi; Paisan Suwannawong; Karyn Kaplan; Evan Wood; Thomas Kerr
Journal:  Harm Reduct J       Date:  2010-05-13

9.  Overdose prevention and naloxone prescription for opioid users in San Francisco.

Authors:  Lauren Enteen; Joanna Bauer; Rachel McLean; Eliza Wheeler; Emalie Huriaux; Alex H Kral; Joshua D Bamberger
Journal:  J Urban Health       Date:  2010-12       Impact factor: 3.671

10.  Can we prevent drug related deaths by training opioid users to recognise and manage overdoses?

Authors:  Romina Lopez Gaston; David Best; Victoria Manning; Ed Day
Journal:  Harm Reduct J       Date:  2009-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.